Rhythm Pharmaceuticals Inc (RYTM)
39.35
-4.53
(-10.32%)
USD |
NASDAQ |
May 07, 16:00
38.01
-1.34
(-3.41%)
Pre-Market: 08:10
Rhythm Pharmaceuticals Cash from Investing (Quarterly): 22.64M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 22.64M |
| September 30, 2023 | -94.96M |
| June 30, 2023 | 48.19M |
| March 31, 2023 | 18.46M |
| December 31, 2022 | -40.78M |
| September 30, 2022 | -39.70M |
| June 30, 2022 | 35.98M |
| March 31, 2022 | 72.52M |
| December 31, 2021 | 7.248M |
| September 30, 2021 | 62.78M |
| June 30, 2021 | 13.52M |
| March 31, 2021 | -145.71M |
| December 31, 2020 | 61.89M |
| September 30, 2020 | 34.91M |
| Date | Value |
|---|---|
| June 30, 2020 | 32.86M |
| March 31, 2020 | 28.87M |
| December 31, 2019 | -139.13M |
| September 30, 2019 | 41.47M |
| June 30, 2019 | 46.14M |
| March 31, 2019 | 23.54M |
| December 31, 2018 | 12.28M |
| September 30, 2018 | -136.47M |
| June 30, 2018 | 16.44M |
| March 31, 2018 | 20.61M |
| December 31, 2017 | -111.45M |
| September 30, 2017 | 6.443M |
| June 30, 2017 | 2.983M |
| March 31, 2017 | -8.019M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-145.71M
Minimum
Mar 2021
72.52M
Maximum
Mar 2022
3.538M
Average
28.87M
Median
Mar 2020
Cash from Investing (Quarterly) Benchmarks
| Pfizer Inc | -11.00B |
| Amicus Therapeutics Inc | -23.96M |
| Insmed Inc | 1.803M |
| Altimmune Inc | -7.959M |
| Regeneron Pharmaceuticals Inc | -1.687B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -29.38M |
| Cash from Financing (Quarterly) | 2.423M |
| Free Cash Flow | -136.20M |
| Free Cash Flow Per Share (Quarterly) | -0.4961 |
| Free Cash Flow to Equity (Quarterly) | -29.38M |
| Free Cash Flow to Firm (Quarterly) | -28.65M |
| Free Cash Flow Yield | -6.00% |